Medindia

X

China-Made Ebola Vaccine Permitted for Overseas Phase Two Clinical Trials

by Dr. Trupti Shirole on  October 13, 2015 at 9:07 PM Clinical Trials News   - G J E 4
The World Health Organization (WHO) has revealed that the Ebola virus has killed over 11,000 people in West Africa so far. A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, West Africa, marking the vaccine's first overseas clinical trial permit.
 China-Made Ebola Vaccine Permitted for Overseas Phase Two Clinical Trials
China-Made Ebola Vaccine Permitted for Overseas Phase Two Clinical Trials
Advertisement

The Chinese Ebola vaccine has three major features- first, the vaccine is the first based on the Ebola virus strain responsible for the West African outbreak in 2014. Until now, all tested Ebola vaccines were based on a virus strain from the Democratic Republic of the Congo outbreak of 1976.

Advertisement
Second, the Chinese vaccine is currently in the form of a freeze-dried powder which will keep it stable for at least two weeks in temperatures of up to 37 degrees Celsius. This will also make it suitable for the tropical West African region and assist with large-scale production.

Thirdly, clinical outcomes have proved the safety and efficacy of the Ebola vaccine. Phase one of clinical trials of the Chinese Ebola vaccine that included human testing indicates that the vaccine is safe.

Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All